An update on peritoneal dialysis solutions

Icodextrin Increases Technique Survival Rate in Peritoneal Dialysis Patients with Diabetic Nephropathy by Improving Body Fluid Management: A Randomized Controlled Trial

(2011) Y. Takatori et al.   Clinical Journal of the American Society of Nephrology

l-Carnitine is an osmotic agent suitable for peritoneal dialysis

(2011) Mario Bonomini et al.   KIDNEY INTERNATIONAL

The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

(2011) Jeffrey Perl et al.   KIDNEY INTERNATIONAL

l-Carnitine: more than just an alternative to glucose as an osmotic agent for peritoneal dialysis?

(2011) Simon J. Davies   KIDNEY INTERNATIONAL

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival

(2011) Shalabh Srivastava et al.   KIDNEY INTERNATIONAL

Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia

(2011) B. L. Riser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease

(2010) Rajnish Mehrotra et al.   ARCHIVES OF INTERNAL MEDICINE

Biocompatible Peritoneal Dialysis Solutions: Do We Have One?

(2010) K. Chaudhary et al.   Clinical Journal of the American Society of Nephrology

Propensity-Matched Mortality Comparison of Incident Hemodialysis and Peritoneal Dialysis Patients

(2010) E. D. Weinhandl et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Cardiovascular risk in the peritoneal dialysis patient

(2010) Raymond T. Krediet et al.   Nature Reviews Nephrology

Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid

(2010) M. A. Bajo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients

(2010) K. H. Oh et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study

(2010) J. H. Cho et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Low-GDP fluid (Gambrosol trio(R)) attenuates decline of residual renal function in PD patients: a prospective randomized study

(2010) M. Haag-Weber et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

THE EFFECTS OF A DIALYSIS SOLUTION WITH A COMBINATION OF GLYCEROL/AMINO ACIDS/DEXTROSE ON THE PERITONEAL MEMBRANE IN CHRONIC RENAL FAILURE

(2010) M. de Graaff et al.   PERITONEAL DIALYSIS INTERNATIONAL

EARLY DIAGNOSTIC MARKERS FOR ENCAPSULATING PERITONEAL SCLEROSIS: A CASE-CONTROL STUDY

(2010) D. E. Sampimon et al.   PERITONEAL DIALYSIS INTERNATIONAL

Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

(2010) David W Johnson et al.   BMC Nephrology

Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions

(2009) Seung Hyeok Han et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Randomized Controlled Trial of Icodextrin versus Glucose Containing Peritoneal Dialysis Fluid

(2009) A. Lin et al.   Clinical Journal of the American Society of Nephrology

Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis

(2009) Dinanda J. de Jager   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study

(2009) S. Kim et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status

(2009) S. Davies et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?

(2008) P. Stenvinkel et al.   Clinical Journal of the American Society of Nephrology

Visceral Fat, Arterial Stiffness, and Endothelial Function in Peritoneal Dialysis Patients

(2008) Qian Lu et al.   JOURNAL OF RENAL NUTRITION

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study

(2008) A. Vychytil et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study

(2008) J. Pajek et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange

(2008) S. J. Davies et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of Icodextrin on Insulin Resistance and Adipocytokine Profiles in Patients on Peritoneal Dialysis

(2008) Fumihiro Takeguchi et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function

(2007) S.L.S. Fan et al.   KIDNEY INTERNATIONAL